Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Felicity Lynch is active.

Publication


Featured researches published by Felicity Lynch.


Immunology Today | 1990

Dissection of an inflammatory process induced by CD8+ T cells

Peter C. Doherty; Jane E. Allan; Felicity Lynch; Rhodri Ceredig

A massive delayed type hypersensitivity (DTH) reaction occurs in the cerebrospinal fluid (CSF) of mice with lymphocytic choriomeningitis (LCM). In this article, Peter Doherty and colleagues analyze this reaction together with the population dynamics of the regional lymph node to give a comprehensive picture of the events underlying this CD8+ T-cell-mediated immunopathological disease. Their findings are of general relevance to the understanding of inflammation.


Cellular Immunology | 1988

Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium lonophore

Zsuzsanna Tabi; Felicity Lynch; Rhodri Ceredig; Jane E. Allan; Peter C. Doherty

Memory lymphocytic choriomeningitis virus (LCMV)-immune cytotoxic T-lymphocyte precursors (CTLp) can be stimulated to proliferate and to mediate specific cytotoxic activity following incubation with phorbol myristate acetate (PMA), calcium ionophore (CaI), and interleukin 2 (IL-2). This protocol can be used to selectively induced virus-specific CTL activity under both bulk culture and limiting dilution conditions, in the absence of added antigen. There is no concurrent stimulation of alloreactive CTLp. Proliferation of the effector Lyt-2+ population in medium containing PMA and CaI requires L3T4+ cells, which can be replaced by adding IL-2, and the development of cytotoxicity is totally IL-2 dependent. The LCMV-specific memory T cells are also characterized by the expression of the Pgp-1 (Ly24) glycoprotein. The availability of this marker, together with the capacity to selectively stimulate primed CTLp in the absence of antigen, should greatly facilitate the analysis of T-cell memory in virus infections.


Human Immunology | 1997

Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog

Rosemarie Hunziker; Felicity Lynch; Ethan M. Shevach; David H. Margulies

To determine whether the function of MHC molecules in tolerance and education is related to cell surface expression, we have produced two strains of transgenic mice in the C57Bl/6 background that express soluble analogs of the H-2D(d) class I protein. The transgenes were stably integrated and genetically transmitted in a Mendelian fashion. Messenger RNA for the hybrid genes was detected in all tissues analyzed in a class I-like pattern of expression, with the highest levels in lymphoid tissues. All mice bearing the transgenes expressed relatively high levels (0.1 mg/ml) of the encoded protein in their serum as assessed by Western blotting and enzyme-linked immunosorbent assay (ELISA). Gel filtration chromatography showed that the soluble H-2D(d) protein exists as a heterodimer with beta2-microglobulin and as higher order multimers in serum. Lymphoid cells from the transgenic mice showed no cell surface expression of the soluble class I protein in indirect immunofluorescence assays. Splenocytes from two independently derived transgenic lines generated primary cytotoxic and proliferative responses directed against membrane H-2D(d) antigens. Mice of both strains rejected tail skin from donors that differed from the B6 background at the H-2D(d) locus only, but with delayed kinetics compared to nontransgenic littermate controls. Mice expressing the transgenic protein on immunization did not produce antibodies that recognized soluble H-2D(d) in ELISA, whereas B6 mice generated strong antibody responses to challenge with splenocytes bearing cell surface H-2D(d). Thus, transgenic mice expressing soluble H-2D(d) were partially tolerant to stimulation by membrane-bound H-2D(d). As with the activation of T-cells, the induction and maintenance of immunologic tolerance apparently displayed different requirements depending upon the T-cell subpopulation involved.


Immunologic Research | 1988

Phenotypic analysis of mouse thymus development

Rhodri Ceredig; Felicity Lynch; Jill Medveczky

ConclusionsIn this review, we have presented some of our data on the developing mouse thymus studied using mAbs to cell surface determinants and FMF. In the past, numerous parameters have been used in an attempt to describe the differentiation of T cells in the thymus. These parameters have included relative cell size, anatomical location, enzyme activity (TdT), expression of surface molecules such as Thy-1, Lyt-1, H-2, PNA, T200, TL, and CD4/CD8, and the ability to express IL-2R [45, 46]. None of these parameters has been adequate to describe how the thymus generates functional ‘mature’ T cells, which now include CD4/CD8 single-positive and double-negative cells, from its small numbers of elusive precursors [17, 45, 47]. However, given the irrefutable evidence that the thymus does influence the repertoire of TcR expressed by cells generated therein [48], analysis of gene regulation and surface expression of TcR molecules by thymocytes is certainly the most promising approach for the elucidation of the mysterious nature of intrathymic T cell differentiation.


Cellular Immunology | 1989

Persistence of the irradiated host component in thymocyte populations from bone marrow radiation chimeras infected with lymphocytic choriomeningitis virus

Felicity Lynch; Rhodri Ceredig; Diana Hartley; Peter C. Doherty

The thymus of chimeras made using T cell-depleted donor bone marrow from Thy1.1+ mice and 950 rad Thy 1.2+ recipients is dominated initially by cells expressing the Thy 1.2+ phenotype of the irradiated host. The thymocyte population recovered at 2 weeks after reconstitution comprises 80% Thy 1.2+ cells (host), the remainder being Thy 1.1+ (donor). This situation is normally reversed within a further week, with the host Ty 1.2+ (donor). This situation is normally reversed within a further week, with the host Thy 1.2+ thymocytes being present at a frequency of less than 5% from Week 4. Infection with lymphocytic choriomeningitis virus (LCMV) at 1 week after reconstitution with bone marrow causes a profound and persistent drop in the total number of thymocytes. The decline is equivalent for all categories of donor-derived thymocytes defined by two-color flow microfluorometric analysis for CD4 and CD8. However, there is a partial compensation by the retention of cells originating from the Thy 1.2+ host, which constitute 30-40% of the total thymocyte pool as late as 8 weeks after administration of bone marrow in the LCMV-infected chimeras. These radiation-resistant precursors give rise to CD4-8-, CD4-8+, CD4+8-, and CD4+8+ thymocytes, with the latter category being present at increased frequency. The potential skewing of the mature T cell repertoire as a consequence of persistent virus infection is discussed.


Journal of Experimental Medicine | 1987

Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis.

Rhodri Ceredig; Jane E. Allan; Zsuzsanna Tabi; Felicity Lynch; Peter C. Doherty


Journal of Immunology | 1989

Phenotypic and functional analysis of the cellular response in regional lymphoid tissue during an acute virus infection.

Felicity Lynch; Peter C. Doherty; Rhodri Ceredig


Proceedings of the National Academy of Sciences of the United States of America | 1987

Phenotypic properties, interleukin 2 production, and developmental origin of a "mature" subpopulation of Lyt-2- L3T4- mouse thymocytes.

Rhodri Ceredig; Felicity Lynch; P Newman


European Journal of Immunology | 1989

Mouse strain variation in Ly-24 (Pgp-1) expression by peripheral T cells and thymocytes: implications for T cell differentiation.

Felicity Lynch; Rhodri Ceredig


International Immunology | 1993

γδ T cells promote CD4 and CD8 expression by SCID thymocytes

Felicity Lynch; Ethan M. Shevach

Collaboration


Dive into the Felicity Lynch's collaboration.

Top Co-Authors

Avatar

Rhodri Ceredig

National University of Ireland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jane E. Allan

Australian National University

View shared research outputs
Top Co-Authors

Avatar

Zsuzsanna Tabi

Australian National University

View shared research outputs
Top Co-Authors

Avatar

Ethan M. Shevach

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Diana Hartley

Australian National University

View shared research outputs
Top Co-Authors

Avatar

Geeta Chaudhri

Australian National University

View shared research outputs
Top Co-Authors

Avatar

Jill Medveczky

Australian National University

View shared research outputs
Top Co-Authors

Avatar

David H. Margulies

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Rosemarie Hunziker

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge